EFMOROCTOCOG ALFA for Haemarthrosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where EFMOROCTOCOG ALFA was used for Haemarthrosis.
Most Reported Side Effects for EFMOROCTOCOG ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 836 | 45.6% | 1 | 100 |
| Traumatic haemorrhage | 139 | 7.6% | 0 | 28 |
| Arthralgia | 137 | 7.5% | 1 | 23 |
| Limb injury | 120 | 6.6% | 0 | 13 |
| Fall | 114 | 6.2% | 1 | 26 |
| Haemarthrosis | 114 | 6.2% | 0 | 11 |
| Spontaneous haemorrhage | 99 | 5.4% | 0 | 13 |
| Joint injury | 97 | 5.3% | 0 | 15 |
| Contusion | 73 | 4.0% | 0 | 5 |
| Head injury | 67 | 3.7% | 0 | 15 |
| Pain | 61 | 3.3% | 0 | 15 |
| Epistaxis | 53 | 2.9% | 0 | 6 |
| Off label use | 52 | 2.8% | 0 | 4 |
| Pain in extremity | 49 | 2.7% | 0 | 11 |
| Weight increased | 48 | 2.6% | 0 | 16 |
Other Indications for EFMOROCTOCOG ALFA
Factor viii deficiency (832)
Haemorrhage (219)
Prophylaxis (61)
Immune tolerance induction (46)
Product used for unknown indication (46)
Haemophilia (34)
Haemorrhage prophylaxis (22)
Other Drugs Used for Haemarthrosis
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (67)
COAGULATION FACTOR IX RECOMBINANT HUMAN (26)
COAGULATION FACTOR IX RECOMBINANT HUMAN\ISOPROPYL ALCOHOL (11)
ANTI-INHIBITOR COAGULANT COMPLEX (9)
COAGULATION FACTOR VIIA RECOMBINANT HUMAN (7)
ANTIHEMOPHILIC FACTOR HUMAN (6)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (6)
EFTRENONACOG ALFA (6)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (5)
DAMOCTOCOG ALFA PEGOL (5)